Jitendra Shrawan Kanodia

7PUBLICATIONS
28CO-AUTHORS
PharmacogenomicsInformation systems philosophy, research methods and theoryCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 23, 2025
Opportunities and Challenges of Hepatic Impairment Physiologically Based Pharmacokinetic Modeling in Drug Development-An IQ Perspective.

Hisham Qosa, Islam R Younis, Vaishali Sahasrabudhe

|Oct 23, 2024
An IQ Industry Perspective on Informing Dosing Recommendations in Patients With Renal Impairment.

Ashish Sharma, Islam R Younis, Jitendra Kanodia

|May 16, 2024
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper.

Divya Samineni, Karthik Venkatakrishnan, Ahmed A Othman

|Jan 18, 2023
International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs.

Ingrid M Pruimboom-Brees, Swati Gupta, Nagendra Chemuturi

|Mar 30, 2021
Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension.

Arthur Lo, Lucy Norcliffe-Kaufmann, Ross Vickery

Pageof 2